[VYNE] QoQ Quarter Result on 31-Dec-2017 [#Q4]

Stock
[VYNE] VYNE Therapeutics Inc.
Announcement Date
28-Mar-2018
Financial Year
2017
Quarter
31-Dec-2017 [#Q4]
Profit Trend
QoQ- -13.52%
YoY- -91.79%
Quarter Report
VYNE's Result
VYNE's Financial Summary
View:
Show?
Quarter Result
30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 CAGR
Revenue 0 10,143 497 2,775 909 449 449 -
PBT -12,847 -8,347 -12,657 -9,277 -8,172 -6,153 -5,474 76.51%
Tax 0 0 0 -2 0 0 0 -
NP -12,847 -8,347 -12,657 -9,277 -8,172 -6,153 -5,474 76.51%
Tax Rate - - - - - - - -
Total Cost 12,847 18,490 13,154 12,052 9,081 6,602 5,923 67.48%
Ratio Analysis
30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 CAGR
NP Margin 0.00 -82.29 -2,546.68 -334.31 -899.01 -1,370.38 -1,219.15 -
Per Share
30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 31/03/17 CAGR
EPS -40.26 -26.28 -51.83 -32.43 -50.99 -38.39 -34.16 11.56%
EPS Diluted -40.26 -26.28 -51.83 -32.43 -50.99 -38.39 -34.16 11.56%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.